Author:
Baker Cristina,Morrison Vicki A.
Reference21 articles.
1. Morrison VA (1998). The infectious complications of chronic lymphocytic leukemia. Semin Oncol 25:98–106.
2. Morrison VA, Rai KR, Peterson B, et al. (2001). The impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: An intergroup study (CALGB 9011). J Clin Oncol 19:3611–3621.
3. Pomeroy C, Oken MM, Rydell RE, Filice GA (1991). Infection in myelodysplastic syndromes. Am J Med 90:338–344.
4. National Comprehensive Cancer Network (2007). Practice Guidelines in Oncology (Prevention and Treatment of Cancer-Related Infections), Volume 2.
5. Smith TJ, Khatcheressian J, Lyman GH, et al. (2006). 2006 Update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 24(19):3187–3205.